Abstract:Response to Angiotensin-(1-7) and Kidney Disease: Friend or FoeWe appreciate Velkoska et al for their interests in our recent publication concerning the effects of angiotensin (Ang)-(1-7) in the rostral ventrolateral medulla (RVLM) on enhanced cardiac sympathetic afferent reflex (CSAR) and sympathetic activation in 2-kidney, 1-clip renovascular hypertensive rats. 1 Indeed, as Velkoska et al have indicated the effects of Ang-(1-7) in patients or experimental models of kidney diseases are controversial. 2Some studies indicate that, as a counter regulator of the classic Ang II/Ang II type 1 (AT 1 ) receptor axis-mediated effects, Ang-(1-7)/Mas receptor axis is expected to play a potential therapeutic role in kidney diseases.However, previous studies in our laboratory have indicated that Ang-(1-7) in the paraventricular nucleus is as effective as Ang II in enhancing the CSAR and increasing sympathetic outflow in 2-kidney, 1-clip rats. 3The increased Ang-(1-7) and Mas receptor activity in RVLM contributes to the enhanced CSAR and excessive sympathetic activation, which could propel the pathogenesis of hypertension and progression of organ damage in renovascular hypertension. 1Velkoska et al also have shown that Ang-(1-7) infusion has major adverse effects of increasing blood pressure and accelerating cardiac hypertrophy and fibrosis in rats with subtotal nephrectomy. 4n addition, Ang-(1-7) causes transition of tubuloepithelial cells into myofibroblasts, which contributes to renal fibrosis. 5Therefore, this leads to the question: is Ang-(1-7) a friend or foe in kidney diseases?This leads to interesting points for discussion that need to be further studied in the future.Our present work focuses on determining the roles of Ang-(1-7) in modulating the CSAR, sympathetic activity, and blood pressure in specific central nuclei, RVLM. 1 It should be noted that we did not investigate the effects of Ang-(1-7) in periphery.The examination of the changes of Ang-(1-7) level in the RVLM after peripheral injection of Ang-(1-7), which was suggested by Velkoska et al might be helpful in determining whether peripheral Ang-(1-7) could cross the blood-brain barrier via the circumventricular organs in the 2-kidney, 1-clip renovascular hypertension model, which requires further study.However, there are not enough evidences to show that Ang-(1-7) in the RVLM is correlated to the circulating Ang-(1-7) level till now.In summary, we are honored in the interest Velkoska et al have shown in our work concerning the effects of Ang-(1-7) in the RVLM on the CSAR and sympathetic activity in renovascular hypertension.The specific roles of Ang-(1-7) in kidney diseases are controversial, so there is more work needed to be done to further understand it.

Effect Of Angiotensin-(1-7) On Vascular Endothelial Cell Function And Correlation With Blood Pressure Variability In Patients With Secondary Hypertension

Relationship between vasoactive substance and blood pressure in old patients with hypertension

Study of the relationship between blood pressure variability and arrhythmia of patients with essential hypertension

[Relationship Between Angiopoietin-2 and Vascular Endothelial Factor and Vasodilation Function in Hypertensive Patients].

Effect of Valsartan for Hypertension Patients on Interleukin1β Secretion in Peripheral Blood Mononuclear Cells

The Relationship Between Blood Pressure Variability and the Plasma Levels of Nitric Oxide and Endothelin-1

The Effects Between Single Long-Acting and Combination of Short-Acting Antihypertensive Drugs Treatment on Visit-to-visit Systolic Blood Pressure Variability

Relationship Between Angiotensin Ⅱ Type 1 Receptor/Autoantibodies in Plasma and Blood Pressure

Effect of blood lipid control on blood pressure variability and coronary events in patients with essential hypertension

Angiotensin-(1-7) Attenuates Hypertension and Cardiac Hypertrophy Via Modulation of Nitric Oxide and Neurotransmitter Levels in the Paraventricular Nucleus in Salt-Sensitive Hypertensive Rats

EFFECTS OF GLYCOSYLATED HEMOGLOBIN LEVEL ON BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS

The relationship between character factors and the level of angiotensin Ⅱ in elderly patients with essential hypertension

Response to Angiotensin-(1–7) and Kidney Disease: Friend or Foe

Plasma Angiotensin Ⅱ Type 2 Receptor in Relevant to Blood Pressure and Inflammatory Factors

Plasma Auto-Antibodies to Angiotensin II Receptors Are Correlated with Blood Pressure and Inflammatory Factors in Hypertension Patients

Relationship Between Blood Pressure Variability and Serum High Sensitive C-reactive Protein and Matrix Metalloproteinase-9 in Patients with Essential Hypertension

Association Of Plasma Angiotensin-(1-7) Level And Left Ventricular Function In Patients With Type 2 Diabetes Mellitus

Inverse Correlation Between Plasma Adropin And Et-1 Levels In Essential Hypertension A Cross-Sectional Study

Association Between the Angiotensin II/Angiotensin (1-7) Imbalance and Left Ventricular Hypertrophy in Patients with Heart Failure

Effect of irbesarten on expression of CD 11b/CD 18 in patients with essential hypertension

Changes and Correlation Between Platelet Activation and Inflammatory Response in Patients with Essential Hypertension